LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma

NCT00062868 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Disease
Non Hodgkin Lymphoma
Lymphoepithelioma
Leiomyosarcoma

Interventions

BIOLOGICAL: LMP1/2 CTLs (ALCI - Group A)
BIOLOGICAL: LMP1/2 CTLs (ALCI - Group B)
BIOLOGICAL: LMP1/2 CTLs (ALCI - Group C)
BIOLOGICAL: LMP2 CTLs (ALSCER - Group A)
BIOLOGICAL: LMP2 CTLs (ALSCER - Group B)
BIOLOGICAL: LMP2 CTLs (ALSCER - Group C)
BIOLOGICAL: LMP1/2 CTLs (ALCI - Expansion - Group A)
BIOLOGICAL: LMP1/2 CTLs (ALCI - Expansion Group B)
BIOLOGICAL: LMP1/2 CTLs (ALCI - Expansion Group C)

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]